Net profit of Glaxosmithkline Pharmaceuticals rose 45.75% to Rs 194.48 crore in the quarter ended March 2024 as against Rs 133.43 crore during the previous quarter ended March 2023. Sales rose 18.08% to Rs 929.80 crore in the quarter ended March 2024 as against Rs 787.45 crore during the previous quarter ended March 2023.For the full year,net profit declined 3.39% to Rs 589.96 crore in the year ended March 2024 as against Rs 610.69 crore during the previous year ended March 2023. Sales rose 6.21% to Rs 3453.71 crore in the year ended March 2024 as against Rs 3251.72 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales929.80787.45 18 3453.713251.72 6 OPM %27.6721.56 -26.3124.73 - PBDT286.32196.75 46 1029.48903.14 14 PBT268.22179.57 49 959.80837.37 15 NP194.48133.43 46 589.96610.69 -3 Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 17 May 2024.Powered by Capital Market - Live News

Net profit of Glaxosmithkline Pharmaceuticals declined 72.22% to Rs 45.72 crore in the quarter ended December 2023 as against Rs 164.56 crore during the previous quarter ended December 2022. Sales rose 0.37% to Rs 805.26 crore in the quarter ended December 2023 as against Rs 802.30 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales805.26802.30 0 OPM %27.0828.51 - PBDT245.85252.03 -2 PBT228.74235.62 -3 NP45.72164.56 -72 Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News

Net profit of Glaxosmithkline Pharmaceuticals rose 12.45% to Rs 217.51 crore in the quarter ended September 2023 as against Rs 193.42 crore during the previous quarter ended September 2022. Sales rose 4.38% to Rs 956.99 crore in the quarter ended September 2023 as against Rs 916.87 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales956.99916.87 4 OPM %30.2528.02 - PBDT317.27278.51 14 PBT299.16262.15 14 NP217.51193.42 12 Powered by Capital Market - Live News